The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden

被引:63
作者
Middeldorp, S
Libourel, EJ
Hamulyák, K
van der Meer, J
Büller, HR
机构
[1] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands
[2] Univ Groningen Hosp, Dept Haematol, Div Haemostasis Thrombosis & Rheol, Groningen, Netherlands
[3] Univ Hosp Maastricht, Dept Haematol, Maastricht, Netherlands
关键词
venous thromboembolism; pregnancy; factor V; Leiden; APC resistance; homozygous;
D O I
10.1046/j.1365-2141.2001.02766.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk of venous thromboembolism (VTE) is increased in pregnancy and during the post-partum period, The absolute risk for pregnancy-related VTE in heterozygous women with the factor V Leiden mutation is approximately 2%, but studies on this risk for homozygous women show conflicting results. In a retrospective family study, we found that the risk of pregnancy-related VTE in women with a symptomatic first-degree relative was 17% per pregnancy (95%CI4.7-37.4). Anticoagulant prophylaxis during the post-partum period appears to be indicated in asymptomatic homozygous women from symptomatic kindred, whereas this could be decided on an individual basis during pregnancy.
引用
收藏
页码:553 / 555
页数:3
相关论文
共 11 条
[1]   Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: Implications for prophylaxis [J].
Friederich, PW ;
Sanson, BJ ;
Simioni, P ;
Zanardi, S ;
Huisman, MV ;
Kindt, I ;
Prandoni, P ;
Buller, HR ;
Girolami, A ;
Prins, MH .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (12) :955-+
[2]  
GINSBERG JS, 1992, THROMB HAEMOSTASIS, V67, P519
[3]  
HELIGREN M, 1995, AM J OBSTET GYNECOL, V173, P210
[5]  
Lindqvist PG, 1999, THROMB HAEMOSTASIS, V81, P532
[6]   The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis [J].
Middeldorp, S ;
Henkens, CMA ;
Koopman, MMW ;
van Pampus, ECM ;
Hamulyák, K ;
van der Meer, J ;
Prins, MH ;
Büller, HR .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) :15-+
[7]  
Pabinger I, 2000, Hematol J, V1, P37, DOI 10.1038/sj.thj.6200005
[8]   WORLD DISTRIBUTION OF FACTOR-V LEIDEN [J].
REES, DC ;
COX, M ;
CLEGG, JB .
LANCET, 1995, 346 (8983) :1133-1134
[9]   HIGH-RISK OF THROMBOSIS IN PATIENTS HOMOZYGOUS FOR FACTOR-V LEIDEN (ACTIVATED PROTEIN-C RESISTANCE) [J].
ROSENDAAL, FR ;
KOSTER, T ;
VANDENBROUCKE, JP ;
REITSMA, PH .
BLOOD, 1995, 85 (06) :1504-1508
[10]   Safety of low-molecular-weight heparin in pregnancy:: A systematic review [J].
Sanson, BJ ;
Lensing, AWA ;
Prins, MH ;
Ginsberg, JS ;
Barkagan, ZS ;
Lavenne-Pardonge, E ;
Brenner, B ;
Dulitzky, M ;
Nielsen, JD ;
Boda, Z ;
Turi, S ;
MacGillavry, MR ;
Hamulyák, K ;
Theunissen, IM ;
Hunt, BJ ;
Büller, HR .
THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) :668-672